<!doctype html><html lang=en><head><meta name=generator content="Hugo 0.79.0"><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta property="og:title" content="The first problem was vaccine supply. Now, it’s demand."><meta name=author content="The Verge"><meta name=keywords content="The-Verge"><meta property="og:title" content="The first problem was vaccine supply. Now, it’s demand."><meta property="og:description" content="A vaccination site at the American Museum of Natural History. | Photo by ANGELA WEISS/AFP via Getty Images  Thursday marked a major milestone in the United States’ COVID-19 vaccination campaign: 200 million shots given in President Biden’s first 100 days in office. Over 40 percent of the US population now has at least one dose of a COVID-19 vaccine. But over the past week, the average number of vaccinations reported per day started to fall."><meta property="og:type" content="article"><meta property="og:url" content="https://news.panz3r.dev/post/31e662a9c14b51c9fa5952af6509b15eac171a488bf4ba3fe47f1b2b919412e8/"><meta property="article:published_time" content="2021-04-24T14:00:00+00:00"><meta property="article:modified_time" content="2021-04-24T14:00:00+00:00"><meta name=twitter:card content="summary"><meta name=twitter:title content="The first problem was vaccine supply. Now, it’s demand."><meta name=twitter:description content="A vaccination site at the American Museum of Natural History. | Photo by ANGELA WEISS/AFP via Getty Images  Thursday marked a major milestone in the United States’ COVID-19 vaccination campaign: 200 million shots given in President Biden’s first 100 days in office. Over 40 percent of the US population now has at least one dose of a COVID-19 vaccine. But over the past week, the average number of vaccinations reported per day started to fall."><link rel="shortcut icon" href=/favicon.ico><link rel=apple-touch-icon sizes=180x180 href=/apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=/favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=/favicon-16x16.png><link rel=mask-icon color=#8a0000 href=/safari-pinned-tab.svg><meta name=msapplication-TileColor content="#8A0000"><link rel=stylesheet type=text/css media=screen href=/css/normalize.min.15dd2454cf02be612cd84be5a0307ecae7e9c84d08f88ab2d1e9332717d10fe9b63484bb4c5352072da0915d1a6d48fa41994fb99c120c891cca431b4448f44d.css integrity="sha512-Fd0kVM8CvmEs2EvloDB+yufpyE0I+Iqy0ekzJxfRD+m2NIS7TFNSBy2gkV0abUj6QZlPuZwSDIkcykMbREj0TQ=="><link rel=stylesheet type=text/css media=screen href=/css/main.min.213824d03b199f0409b76c8566e3f3e4fbbe8f03c184b43a665128ee2120bbf3704a1d62249e92ad27ba4c158e21f02299e52148b06efa51a5e54824bfdf6f95.css integrity="sha512-ITgk0DsZnwQJt2yFZuPz5Pu+jwPBhLQ6ZlEo7iEgu/NwSh1iJJ6SrSe6TBWOIfAimeUhSLBu+lGl5Ugkv99vlQ=="><link rel=stylesheet type=text/css media=screen href=/css/all.min.7f32dbc7bd58ff2403d30d3f50cb1c7bbde2de8c48b5c7766b604af90fd927f49223416329d86b9c726d5d06389614ff769288a82570d962a1e50f19efd4b0ce.css integrity="sha512-fzLbx71Y/yQD0w0/UMsce73i3oxItcd2a2BK+Q/ZJ/SSI0FjKdhrnHJtXQY4lhT/dpKIqCVw2WKh5Q8Z79Swzg=="><title>The first problem was vaccine supply. Now, it’s demand. | Panz3r News</title></head><body><header><div id=titletext><h2 id=title><a href=https://news.panz3r.dev/>Panz3r News</a></h2></div><div id=title-description><div id=social><nav><ul><li><a href=https://github.com/panz3r/news-feed><i title=Github class="icons fab fa-github"></i></a></li><li><a href=/index.xml><i title=RSS class="icons fas fa-rss"></i></a></li></ul></nav></div></div><div id=mainmenu><nav><ul><li><a href=/>Home</a></li><li><a href=/tags>Tags</a></li></ul></nav></div></header><main><div class=post><div class=author><p>From <a href=https://www.theverge.com/2021/4/24/22399889/vaccine-supply-demand-antivirus-newsletter-covid target=_blank rel="noopener noreferrer">The Verge</a></p></div><div class=post-header><div class=meta><div class=date><span class=day>24</span>
<span class=rest>Apr 2021</span></div></div><div class=matter><h1 class=title>The first problem was vaccine supply. Now, it’s demand.</h1></div></div><div class=markdown><figure><img alt="A statue of a blue whale with a band-aid on its fin hangs above a vaccination site." src="https://cdn.vox-cdn.com/thumbor/4HVV0FG_T2T9Y9pHHOw6my67xds=/0x0:5776x3851/1310x873/cdn.vox-cdn.com/uploads/chorus_image/image/69180275/1232482373.0.jpg"><figcaption>A vaccination site at the American Museum of Natural History. | Photo by ANGELA WEISS/AFP via Getty Images</figcaption></figure><p id=PFK6XR>Thursday marked a major milestone in the United States’ COVID-19 vaccination campaign: 200 million shots given in President Biden’s first 100 days in office. Over 40 percent of the US population now has at least one dose of a COVID-19 vaccine.</p><p id=pidgWd>But over the past week, the average number of vaccinations reported per day started to fall. Last week, the US was averaging around 3.3 million shots per day. This week, that number dropped to around 3 million shots per day.</p><div class=c-float-right><div id=hwHHuM><div data-anthem-component=aside:9360449></div></div></div><p id=tgaSDY>Every one of those shots takes us another step closer to the end of the pandemic in the US. The slowing pace, though, is a warning sign that we’re reaching an inflection point where the supply of COVID-19 vaccines will outpace the demand. It’s already happening in <a href=https://www.politico.com/news/2021/04/21/states-covid-vaccine-problem-483872>some...</a></p><p><a href=https://www.theverge.com/2021/4/24/22399889/vaccine-supply-demand-antivirus-newsletter-covid>Continue reading…</a></p></div><div class=tags><div class=taxosfloating_left><p>Tags</p></div><div class=termsfloating_right><p><a href=/tags/the-verge/>the-verge</a></p></div><div class=clearit></div></div></div></main><footer><a href=https://github.com/panz3r>Panz3r</a> 2020 | <a href=https://github.com/panz3r/hugo-vitae>Vitae</a> theme for <a href=https://gohugo.io>Hugo</a></footer></body></html>